What You Should Know: - Inovalon, a provider of cloud-based software solutions empowering data-driven healthcare, today announced the establishment of a Preferred Data Partner Program. - The program aims to work with a select number of leading organizations that are committed to the thoughtful application of data towards the improvement of economics and outcomes across the healthcare ecosystem. HealthVerity Partnership With the establishment of this program, Inovalon is
Read More
Real World Evidence (RWE)
OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand RWE
What You Should Know: - OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. - Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient characteristics, symptoms, treatments, clinical outcomes and healthcare resource utilization. Rapidly growing, the CRS and Asthma datasets each follow approximately 500,000 patients in the U.S. -
Read More
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know: Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months. Parkinson’s Disease Premium Dataset Nearly
Read More
FDA Taps Flatiron for 5-Year Real-World Data Collaboration
What You Should Know: Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World Data (RWD) and explore the potential strengths and limitations of using Real World Evidence (RWE) for regulatory purposes.The partnership will specifically evaluate RWD study designs and analytic methods through the collaborative development of priority, clinically
Read More
Surgo Health Launches RWD-Driven Socio-Behavioral Analytics Platform
What You Should Know: - Surgo Health, a new healthcare technology company dedicated to personalized care announced its official launch in Washington, D.C. - Formed as a public benefits company (PBC), Surgo Health is building on the analytics and proprietary data assets from Surgo Ventures and is developing a revolutionary socio-behavioral analytics platform and generating novel, real-world data to enable a greater understanding of the complex factors that influence how individuals engage
Read More
Aetion, FDA to Evaluate Real-World Data Standardization for COVID-19
What You Should Know: - Aetion, a provider of real-world evidence (RWE) technology and analytics, today announced that the FDA has extended Aetion’s contract to evaluate real-world data (RWD) involving COVID-19 medical countermeasures. - Aetion will be expanding its work to evaluate data standardization in the context of COVID-19. Aetion has been collaborating with FDA since May 2020, providing validated software platform capabilities and RWD/E expertise to contribute to rapid evidence
Read More
Innovaccer Launches Connected Digital Health Solution for Biopharma & Medtech
What You Should Know: - Today Innovaccer, the Health Cloud company, announced its Connected Digital Health solution, a new way for life sciences companies to rapidly deliver next-generation digital apps that surround therapeutics and devices with highly engaging patient experiences, improve clinical outcomes, and generate valuable real-world evidence (RWE). - The new solution will allow life sciences companies to realize the promise of digital health with holistic, “around-the-brand”
Read More
Tempus Launches Psychiatric Real-World Data Collaboration
What You Should Know: - Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform mental health treatment. - Tempus N+ is a collaboration between provider institutions across the country and Tempus to build an infrastructure for data-driven research – providers can seamlessly and securely contribute molecular and clinical data, and in turn, their clinicians and researchers can access a
Read More
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected technologies and social media have had on the way we experience our world, it’s somehow even more challenging to fully grasp the scale of it. For health researchers, this data explosion – and especially the rise
Read More
ConcertAI Raises $150M at $1.9 Billion Valuation for RWD Platform
What You Should Know: - ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B valuation. - From its startup just five years ago, ConcertAI has emerged as one of the fastest-growing companies providing high-value software-as-a-service (SaaS) and data solutions to life sciences and biopharma companies, leading healthcare providers, contract
Read More
